Positive news for patients of any HCV genotypes! After treatment with AbbVie’s new pangenotypic regimen of glecaprevir/pibrentasvir, results have shown an average SVR rate of 97.5% across all HCV genotypes in only 8 weeks of therapy.
VIDEO: Pangenotypic regimen leads to h... - Hepatitis C Support
VIDEO: Pangenotypic regimen leads to high SVR in all HCV genotypes
![HFIAdmin profile image](https://images.hu-production.be/avatars/3a72542ae9cb25729a4691dff7338807_small@2x_100x100.jpg)
Written by
![HFIAdmin profile image](https://images.hu-production.be/avatars/3a72542ae9cb25729a4691dff7338807_small@2x_100x100.jpg)
HFIAdmin
To view profiles and participate in discussions please or .
3 Replies
•
That's great but what about sides, during/post treatment?
Not what you're looking for?
You may also like...
In a state of despair....
Hi all i have just found out i have this this year and i managed to get to week 7 and i couldnt...
Finished Mavyret Treatment
Hello everyone!I finished my treatment 2 weeks ago and my last labs show the virus is...
Mavyret treatment
Hi Everyone!
After 4 years of waiting for treatment I am starting my 8 weeks Mavyret treatment.
I...
Hep C for over 25 years, maybe a lot longer
I was diagnosed with Hep C when I gave blood at the blood bank some 25 years ago. Who knows how...
I did mavyret for 8 weeks at 4wks I was >15 at 8 wks I was undetected.. so there is a difference I’m guessing?? Anyone had similar results
Just really uncertain if I’m hcv free or not